Naxitamab Activity in Neuroblastoma Cells Is Enhanced by Nanofenretinide and Nanospermidine
Neuroblastoma cells highly express the disialoganglioside GD2, a tumor-associated carbohydrate antigen, which is also expressed in neurons, skin melanocytes, and peripheral nerve fibers. Immunotherapy with monoclonal anti-GD2 antibodies has a proven efficacy in clinical trials and is included in the...
Saved in:
Main Authors: | Lucrezia Galassi (Author), Martina Rossi (Author), Pietro Lodeserto (Author), Monia Lenzi (Author), Francesca Borsetti (Author), Manuela Voltattorni (Author), Giovanna Farruggia (Author), Paolo Blasi (Author), Isabella Orienti (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanospermidine in Combination with Nanofenretinide Induces Cell Death in Neuroblastoma Cell Lines
by: Pietro Lodeserto, et al.
Published: (2022) -
Antiproliferative and Morphological Effects of Fenretinide Lipid Nanosystems in Colon Adenocarcinoma Cells
by: Lorenzo Anconelli, et al.
Published: (2024) -
A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model
by: Orienti I, et al.
Published: (2019) -
Molecular Genetics in Neuroblastoma Prognosis
by: Margherita Lerone, et al.
Published: (2021) -
Neuroblastoma
Published: (2013)